Epigenetic disorder plays a fundamental role in the etiology of type 2 diabetes
Tóm tắt
Type 2 diabetes (T2D) is now considered a pandemic noncommunicable disease, and the prevalence is still increasing steadily worldwide. Several lines of evidence, including T2D, is an aging-related disease, and the phenomenon of the metabolic memory and developmental origins of adult diabetes argues that epigenetic disorder plays critical roles in the development of T2D. Environmental factors can affect epigenetics during early fetal life until adulthood. Altered epigenetics can be maintained during mitosis and meiosis, so that the subsequent response to environmental cue in later life has also been altered. Epigenetic aberrations affect miRNA expression and functions, and altered miRNA expression can also affect expression of many genes including those relevant to epigenetics. Thus, the development of T2D is an accumulative process that may involve complex interactions between altered transcription factors, miRNA functions, and increased epigenetics disorder in response to environmental stimuli during different stages of life.
Tài liệu tham khảo
Media Centre of WHO. Diabetes [EB/OL]. [2011-11-20] http://www.who.int/mediacentre/factsheets/fs312/en/index.html
Ford E S, Giles W H, Dietz W H. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey [J]. Jama, 2002, 287(3): 356–359.
Yang W, Lu J, Weng J, et al. Prevalence of diabetes among men and women in China [J]. N Engl J Med, 2011, 362(12): 1090–1101.
Wild S, Roglic, G, Green A, et al. Global Prevalence of Diabetes: Estimates for the year 2000 and projections for 2030 [J]. Diabetes Care, 2004, 27(5): 1047–1053.
Shaw J E, Sicree R A, Zimmet P Z. Global estimates of the prevalence of diabetes for 2010 and 2030 [J]. Diabetes research and clinical practice, 2010, 87(1): 4–14.
Hildrum B, Mykletun A, Hole T, et al. Age-specific prevalence of the metabolic syndrome defined by the International Diabetes Federation and the National Cholesterol Education Program: the Norwegian HUNT 2 study [J]. BMC public health, 2007, 7: 220.
Rando T A. Epigenetics and aging [J]. Exp gerontol, 2010, 45(4): 253–254.
Bandyopadhyay D, Medrano E E. The emerging role of epigenetics in cellular and organismal aging [J]. Exp gerontol, 2003, 38(11–12): 1299–1307.
Fraga M F, Esteller M. Epigenetics and aging: the targets and the marks [J]. Trends Genet, 2007, 23(8): 413–418.
Thompson R F, Atzmon G, Gheorghe C, et al. Tissue-specific dysregulation of DNA methylation in aging [J]. Aging Cell, 2010, 9(4): 506–518.
Silva S, Martins Y, Matias A, et al. Why are monozygotic twins different? [J]. J Perinat Med, 2011, 39(2): 195–202.
Kaminsky Z A, Tang T, Wang S C, et al. DNA methylation profiles in monozygotic and dizygotic twins [J]. Nat Genet, 2009, 41(2): 240–245.
Gervin K, Hammero M, Akselsen H E, et al. Extensive variation and low heritability of DNA methylation identified in a twin study [J]. Genome Res, 2011, 21(11): 1813–1821.
Pietilainen K H, Rissanen A, Laamanen M, et al. Growth patterns in young adult monozygotic twin pairs discordant and concordant for obesity [J]. Twin Res, 2004, 7(5): 421–429.
Hales C N, Barker D J, Clark, P M. et al. Fetal and infant growth and impaired glucose tolerance at age 64 [J]. Bmj (Clinical Research Ed), 1991, 303(6809): 1019–1022.
Hales C N, Barker D J P. Type 2 (non-insulin-dependent) diabetes mellitus: The thrifty phenotype hypothesis [J]. Diabetologia, 1992, 35: 595–601.
Hales C N, Barker D J. The thrifty phenotype hypothesis [J]. Br Med Bull, 2001, 60: 5–20.
Zhang Junlong, Wang Chunli, Terroni P L. et al. High-unsaturated-fat, high-protein, and low-carbohydrate diet during pregnancy and lactation modulates hepatic lipid metabolism in female adult offspring [J]. Am J Physiol Regul Integr Comp Physiol, 2005, 288(1): R112–118.
Zhang Junlong, Lewis R M, Wang Chunli, et al. Maternal dietary iron restriction modulates hepatic lipid metabolism in the fetuses [J]. Am J Physiol Regul Integr Comp Physiol, 2005, 288(1): R104–111.
Ozanne S E, Olsen G S, Hansen L L, et al. Early growth restriction leads to down regulation of protein kinase C zeta and insulin resistance in skeletal muscle [J]. J Endocrinol, 2003, 177(2): 235–241.
Khan I Y, Yaylor P D, Dekou V, et al. A high fat diet during rat pregnancy programmes regional differences in the function of isolated resistance arteries in the adult offspring [J]. J Vasc Res, 2002, 39: 51.
Trottier G, Koski K G, Brun T, et al. Increased fat intake during lactation modifies hypothalamic-pituitary-adrenal responsiveness in developing rat pups: a possible role for leptin [J]. Endocrinology, 1998, 139(9): 3704–3711.
Heijmans B T, Tobi E W, Stein A D, et al. Persistent epigenetic differences associated with prenatal exposure to famine in humans [J]. Proc Natl Acad Sci USA, 2008, 105(44): 17046–17049.
Lillycrop Karen A, Phillips Emma S, Jackson Alan A, et al. Dietary Protein Restriction of Pregnant Rats Induces and Folic Acid Supplementation Prevents Epigenetic Modification of Hepatic Gene Expression in the Offspring [J]. J Nutr. 2005, 135(6): 1382–1386.
Plagemann A, Harder T, Brunn M, et al. Hypothalamic proopiomelanocortin promoter methylation becomes altered by early overfeeding: an epigenetic model of obesity and the metabolic syndrome [J]. J Physiol, 2009, 587(Pt 20): 4963–4976.
Mudd S H, Cantoni G L. Activation of methionine for transmethylation. III. The methionine-activating enzyme of Bakers’ yeast [J]. J Biol Chem, 1958, 231(1): 481–492.
Cantoni G L. Biological methylation: selected aspects [J]. Annu Rev Biochem, 1975, 44: 435–451.
Sinclair K D, Allegrucci C, Singh R, et al. DNA methylation, insulin resistance, and blood pressure in offspring determined by maternal periconceptional B vitamin and methionine status [J]. Proc Natl Acad Sci USA, 2007, 104(49): 19351–19356.
Vickers M H, Breier B H, Cutfield W S, et al. Fetal origins of hyperphagia, obesity, and hypertension and postnatal amplification by hypercaloric nutrition [J]. Am J Physiol Endocrinol Metab, 2000, 279: E83–E87.
Vickers M H, Gluckman P D, Coveny A H et al. Neonatal leptin treatment reverses developmental programming [J]. Endocrinology, 2005, 146(10): 4211–4216.
Gluckman P D, Lillycrop K A, Vickers M H, et al. Metabolic plasticity during mammalian development is directionally dependent on early nutritional status [J]. Proc Natl Acad Sci U S A, 2007, 104(31): 12796–12800.
Caldji C, Tannenbaum B, Sharma S, et al. Maternal care during infancy regulates the development of neural systems mediating the expression of fearfulness in the rat [J]. Proc Natl Acad Sci USA, 1998, 95(9): 5335–5340.
Weaver I C, Cervoni N, Champagne F A, et al. Epigenetic programming by maternal behavior [J]. Nat Neurosci, 2004, 7(8): 847–854.
Weaver I C, Champagne F A, Brown S E, et al. Reversal of maternal programming of stress responses in adult offspring through methyl supplementation: Altering epigenetic marking later in life [J]. J Neurosci, 2005, 25(47): 11045–11054.
Pedersen O, Kahn C R, Flier J S, et al. High fat feeding causes insulin resistance and a marked decrease in the expression of glucose transporters (Glut 4) in fat cells of rats [J]. Endocrinology, 1991, 129(2): 771–777.
Akiyama T, Tachibana I, Shirohara H. et al. High-fat hypercaloric diet induces obesity, glucose intolerance and hyperlipidemia in normal adult male Wistar rat [J]. Diabetes Res Clin Pract, 1996, 31(1–3): 27–35.
Bruce K D, Cagampang F R, Argenton M, et al. Maternal high-fat feeding primes steatohepatitis in adult mice offspring, involving mitochondrial dysfunction and altered lipogenesis gene expression [J]. Hepatology, 2009, 50(6): 1796–1808.
Torrens C, Poston L, Hanson M A. Transmission of raised blood pressure and endothelial dysfunction to the F2 generation induced by maternal protein restriction in the F0, in the absence of dietary challenge in the F1 generation [J]. Br J Nutr, 2008, 100(4): 760–766.
Harrison M, Langley-Evans S C. Intergenerational programming of impaired nephrogenesis and hypertension in rats following maternal protein restriction during pregnancy [J]. Br J Nutr,, 2009, 101(7): 1020–1030.
Gniuli D, Calcagno A, Caristo M E, et al. Effects of high-fat diet exposure during fetal life on type 2 diabetes development in the progeny [J]. J LipRes, 2008, 49(9): 1936–1945.
Burdge G C, Hanson M A, Slater-Jefferies J L, et al. Epigenetic regulation of transcription: a mechanism for inducing variations in phenotype (fetal programming) by differences in nutrition during early life? [J]. Br J Nutr, 2007, 97(6): 1036–1046.
Waterland R A, Travisano M, Tahiliani K G. Diet-induced hypermethylation at agouti viable yellow is not inherited transgenerationally through the female [J]. Faseb J, 2007, 21(12): 3380–3385.
Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: The Epidemiology of Diabetes Interventions and Complications (EDIC) study [J]. Jama, 2003, 290(16): 2159–2167.
UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) [J]. Lancet, 1998, 352(9131): 837–853.
Holman R R, Paul S K, Bethel M A, et al. Long-term follow-up after tight control of blood pressure in type 2 diabetes [J]. N Engl J Med, 2008, 359(15): 1565–1576.
Holman R R, Paul S K, Bethel M A, et al. 10-year follow-up of intensive glucose control in type 2 diabetes [J]. N Engl J Med, 2008, 359(15): 1577–1589.
Nathan D M, Cleary P A, Backlund J Y, et al. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes [J]. N Engl J Med, 2005, 353(25): 2643–2653.
Pirola L, Balcerczyk A, Okabe J, et al. Epigenetic phenomena linked to diabetic complications [J]. Nat Rev Endocrinol, 2010, 6(12): 665–675.
Brasacchio D, Okabe J, Tikellis C, et al. Hyperglycemia induces a dynamic cooperativity of histone methylase and demethylase enzymes associated with gene-activating epigenetic marks that coexist on the lysine tail [J]. Diabetes, 2009, 58(5): 1229–1236.
Villeneuve L M, Reddy M A, Lanting L L, et al. Epigenetic histone H3 lysine 9 methylation in metabolic memory and inflammatory phenotype of vascular smooth muscle cells in diabetes [J]. Proc Natl Acad Sci USA, 2008, 105(26): 9047–9052.
Li S L, Reddy M A, Cai Q, et al. Enhanced proatherogenic responses in macrophages and vascular smooth muscle cells derived from diabetic db/db mice [J]. Diabetes, 2006, 55(9): 2611–2619.
Lee R C, Feinbaum R L, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14 [J]. Cell, 1993, 75(5): 843–854.
Wightman B, Ha I, Ruvkun G. Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans [J]. Cell, 1993, 75(5): 855–862.
Olsen P H, Ambros V. The lin-4 regulatory RNA controls developmental timing in Caenorhabditis elegans by blocking LIN-14 protein synthesis after the initiation of translation [J]. Dev Biol, 1999, 216(2): 671–680.
Lagos-Quintana M, Rauhut R, Lendeckel W, et al. Identification of novel genes coding for small expressed RNAs [J]. Science, 2001, 294(5543): 853–858.
Lagos-Quintana M, Rauhut R, Meyer J, et al. New microRNAs from mouse and human [J]. Rna, 2003, 9(2): 175–179.
Lim L P, Lau N C, Weinstein E G, et al. The microRNAs of Caenorhabditis elegans [J]. Genes Dev, 2003, 17(8): 991–1008.
Pasquinelli A E, Reinhart B J, Slack F, et al. Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA [J]. Nature, 2000, 408(6808): 86–89.
Zamore P D, Haley B. Ribo-gnome: the big world of small RNAs [J]. Science, 2005, 309(5740): 1519–1524.
Selbach M, Schwanhausser B, Thierfelder N, et al. Widespread changes in protein synthesis induced by microRNAs [J]. Nature, 2008, 455(7209): 58–63.
Wienholds E, Plasterk R H A. MicroRNA function in animal development [J]. FEBS Letters, 2005, 579(26): 5911–5922.
Liu W, Mao S Y, Zhu W Y Impact of tiny miRNAs on cancers [J]. World J Gastroenterol, 2007, 13(4): 497–502.
Oakley E J, Van Zant G. Unraveling the complex regulation of stem cells: implications for aging and cancer [J]. Leukemia, 2007, 21(4): 612–621.
Boehm M, Slack F J. MicroRNA control of lifespan and metabolism [J]. Cell Cycle, 2006, 5(8): 837–840.
Gauthier Benoit R, Wollheim Claes B. MicroRNAs: ‘ribo-regulators’; of glucose homeostasis [J]. Nat Med, 2006, 12(1): 36–38.
Krutzfeldt Jan, Stoffel Markus. MicroRNAs: A new class of regulatory genes affecting metabolism [J]. Cell Metab, 2006, 4(1): 9–12.
Poy M N, Eliasson L, Krutzfeldt J, et al. A pancreatic islet-specific microRNA regulates insulin secretion [J]. Nature, 2004, 432(7014): 226–230.
Krutzfeldt J, Rajewsky N, Braich R, et al. Silencing of microRNAs in vivo with ‘antagomirs’ [J]. Nature, 2005, 438(7068): 685–689.
Esau C, Kang X, Peralta E, et al. MicroRNA-143 Regulates Adipocyte Differentiation [J]. J Biol Chem, 2004, 279(50): 52361–52365.
He A, Zhu L, Gupta N, et al. Over-expression of miR-29, highly upregulated in diabetic rats, leads to insulin resistance in 3T3-L1 adipocytes [J]. Mol Endocrinol, 2007, 21: 2785–2794.
Zampetaki A, Kiechl S, Drozdov I, et al. Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes [J]. Circ Res, 107(6): 810–817.
Han L, Witmer P D, Casey E, et al. DNA methylation regulates MicroRNA expression [J]. Cancer Biol Ther, 2007, 6(8): 1284–1288.
Xu J, Liao X, Lu N, et al. Chromatin-modifying drugs induce miRNA-153 expression to suppress Irs-2 in glioblastoma cell lines [J]. International journal of cancer, 2011, 129(10): 2527–2531.
Li X, Liu J, Zhou R, et al. Gene silencing of MIR22 in acute lymphoblastic leukaemia involves histone modifications independent of promoter DNA methylation [J]. Br J Haematol, 2010, 148(1): 69–79.
Chen J F, Mandel E M, Thomson J M, et al. The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation [J]. Nat Genet, 2006, 38(2): 228–233.
Garzon R, Liu S, Fabbri M, et al. MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1 [J]. Blood, 2009, 113(25): 6411–6418.
Zhang J, Zhang F, Didelot X, et al. Maternal high fat diet during pregnancy and lactation alters hepatic expression of insulin like growth factor-2 and key microRNAs in the adult offspring [J]. BMC genomics, 2009, 10: 478.
Reinhart B J, Slack F J, Basson M, et al. The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans [J]. Nature, 2000, 403(6772): 901–906.
Slack F J, Basson M, Liu Z, et al. The lin-41 RBCC gene acts in the C. elegans heterochronic pathway between the let-7 regulatory RNA and the LIN-29 transcription factor [J]. Mol Cell, 2000, 5(4): 659–669.
Esau C, Davis S, Murray S F, et al. miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting [J]. Cell Metab, 2006, 3(2): 87–98.
Shah Y M, Morimura K, Yang Q, et al. Peroxisome proliferator-activated receptor alpha regulates a microRNA-mediated signaling cascade responsible for hepatocellular proliferation [J]. Mol Cell Biol, 2007, 27(12): 4238–4247.
Gonzalez F J, Shah Y M. PPARalpha: mechanism of species differences and hepatocarcinogenesis of peroxisome proliferators [J]. Toxicology, 2008, 246(1): 2–8.
Grosshans H, Johnson T, Reinert K L, et al. The temporal patterning microRNA let-7 regulates several transcription factors at the larval to adult transition in C. elegans [J]. Dev Cell, 2005, 8(3): 321–330.
Tugwood J D, Issemann I, Anderson R G, et al. The mouse peroxisome proliferator activated receptor recognizes a response element in the 5′ flanking sequence of the rat acyl CoA oxidase gene [J]. Embo J, 1992, 11: 433–439.
Zhang B, Marcus S L, Sajjadi F G, et al. Identification of a peroxisome proliferator-responsive element upstream of the gene encoding rat peroxisomal enoyl-CoA hydratase/3-hydroxyacyl-CoA dehydrogenase [J]. PNAS, 1992, 89(16): 7541–7545.
Gulick T, Cresci S, Caira T, et al. The Peroxisome proliferator-activated receptor regulates mitochondrial fatty acid oxidative enzyme gene expression [J]. PNAS, 1994, 91(23): 11012–11016.
Rodriguez J C, Gil Gomez G, Hegardt F G, et al. Peroxisome proliferator-activated receptor mediates induction of the mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase gene by fatty acids [J]. J Biol Chem, 1994, 269(29): 18767–18772.
Muerhoff A S, Griffin K J, Johnson E F. The peroxisome proliferator-activated receptor mediates the induction of CYP4A6, a cytochrome P450 fatty acid omega-hydroxylase, by clofibric acid [J]. J Biol Chem, 1992, 267(27): 19051–19053.
Aldridge T C, Tugwood J D, Green S. Identification and characterization of DNA elements implicated in the regulation of CYP4A1 transcription. [J]. Biochem J, 1995, 306: 473–479.
Hu J F, Nguyen P H, Pham N V, et al. Modulation of Igf2 genomic imprinting in mice induced by 5-azacytidine, an inhibitor of DNA methylation [J]. Mol Endocrinol, 1997, 11(13): 1891–1898.
Kovacheva V P, Mellott T J, Davison J M, et al. Gestational choline deficiency causes global and Igf2 gene DNA hypermethylation by up-regulation of Dnmt1 expression [J]. J Biol Chem, 2007, 282(43): 31777–31788.
Burdge G C, Slater-Jefferies J, Torrens C, et al. Dietary protein restriction of pregnant rats in the F0 generation induces altered methylation of hepatic gene promoters in the adult male offspring in the F1 and F2 generations [J]. Br J Nutr, 2007, 97(3): 435–439.